TABLE 4.
Results After Inverse Probability of Treatment Weighting of Patients With and Without CCO, Stratified by CAS and CEA
| Outcome | CAS Cohort | CEA Cohort | ||
|---|---|---|---|---|
| OR (95% Cl) (CCO vs. No CCO) | OR (95% Cl) (CCO vs. No CCO) | |||
| Death, stroke, and MI | 0.93 (0.71–1.20) | 0.56 | 1.69 (1.25–2.27) | <0.01 |
| Death and stroke | 0.95 (0.72–1.25) | 0.70 | 1.70 (1.23–2.34) | <0.01 |
| Death | 1.30 (0.75–2.24) | 0.35 | 2.23 (1.26–3.95) | <0.01 |
| Stroke | 0.92 (0.69–1.24) | 0.59 | 1.79 (1.20–2.42) | <0.01 |
| MI | 0.78 (0.34–1.81) | 0.56 | 1.76 (0.96–3.23) | 0.07 |
| TIA | 1.06 (0.73–1.52) | 0.07 | 1.05 (0.42–2.61) | 0.91 |